CCR5
protein-codingC-C motif chemokine receptor 5, the group of CD molecules|C-C motif chemokine receptors
Gene summary
This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]
- CMKBR5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CCR5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001394783.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 4 | ||||
| missense | 33 | 1 | 2 | 36 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 34 | 5 | 3 | 42 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001381712.1 | 1 | MANE Select | |
| Ensembl | ENSP00000292303.4 | 1 | MANE Select | |
| RefSeq | NP_000570.1 | 1 | Standard | |
| RefSeq | NP_001093638.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human)
- Endocytosis - Homo sapiens (human)
- Chemokine signaling pathway - Homo sapiens (human)
- Toxoplasmosis - Homo sapiens (human)
- Viral carcinogenesis - Homo sapiens (human)
Biological Process
- MAPK cascade
- dendritic cell chemotaxis
- calcium ion transport
- chemotaxis
- inflammatory response
Molecular Function
- virus receptor activity
- actin binding
- phosphatidylinositol phospholipase C activity
- chemokine receptor activity
- protein binding
Cellular Component
- cytoplasm
- endosome
- plasma membrane
- integral component of plasma membrane
- external side of plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000343801
- Coding exons
- 1
- Length
- 6065
- Individuals with no LoFs
- 107830
- Homozygous LoFs
- 970
- Heterozygous LoFs
- 16943
- Defined
- 125743
- p
- 0.0740
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.46 | 242 | 186 | 1.30 | 0.00000990 | 2313 |
| Missense (PolyPhen) | 74 | 53.581 | 1.3811 | 728 | ||
| Synonymous | -1.20 | 92 | 78.4 | 1.17 | 0.00000456 | 711 |
| Loss of Function | -1.33 | 12 | 7.94 | 1.51 | 4.10e-7 | 96 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.021 | 0.021 | notable |
| Latino/Admixed American | 0.030 | 0.030 | notable |
| Ashkenazi Jewish | 0.13 | 0.13 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.13 | 0.13 | notable |
| European (Non-Finnish) | 0.11 | 0.11 | notable |
| South Asian | 0.016 | 0.016 | notable |
| Other | 0.075 | 0.073 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. {ECO:0000269|PubMed:10383387, ECO:0000269|PubMed:11323418, ECO:0000269|PubMed:8639485, ECO:0000269|PubMed:8663314, ECO:0000269|PubMed:8699119}.;
- Disease
- DISEASE: Diabetes mellitus, insulin-dependent, 22 (IDDM22) [MIM:612522]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:19073967}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.807
- RVIS EVS
- 0.49
- RVIS percentile EVS
- 79.52
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.869
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |